P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE

Bibliographic Details
Main Authors: Anne Troldborg, Bent Deleuran, Lauren Remkus, Daniel Eek
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Lupus Science and Medicine
_version_ 1797260056159322112
author Anne Troldborg
Bent Deleuran
Lauren Remkus
Daniel Eek
author_facet Anne Troldborg
Bent Deleuran
Lauren Remkus
Daniel Eek
author_sort Anne Troldborg
collection DOAJ
first_indexed 2024-04-24T23:19:15Z
format Article
id doaj.art-2bba8e53a12c4cb58b73f9c9a3395b9f
institution Directory Open Access Journal
issn 2053-8790
language English
last_indexed 2024-04-24T23:19:15Z
publishDate 2024-03-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj.art-2bba8e53a12c4cb58b73f9c9a3395b9f2024-03-16T16:30:08ZengBMJ Publishing GroupLupus Science and Medicine2053-87902024-03-0111Suppl 110.1136/lupus-2024-el.187P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLEAnne Troldborg0Bent Deleuran1Lauren Remkus2Daniel Eek3Biomedicine, Aarhus University, Aarhus, DenmarkDepartment of Biomedicine, Aarhus University, Aarhus, Denmark4AstraZeneca A/S, Copenhagen, Denmark5AstraZeneca AB, Södertälje, Sweden
spellingShingle Anne Troldborg
Bent Deleuran
Lauren Remkus
Daniel Eek
P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
Lupus Science and Medicine
title P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
title_full P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
title_fullStr P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
title_full_unstemmed P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
title_short P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
title_sort p133 anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with sle
work_keys_str_mv AT annetroldborg p133anifrolumabtreatmentimprovesqualityoflifeanddecreasescorticosteroiduseinpatientswithsle
AT bentdeleuran p133anifrolumabtreatmentimprovesqualityoflifeanddecreasescorticosteroiduseinpatientswithsle
AT laurenremkus p133anifrolumabtreatmentimprovesqualityoflifeanddecreasescorticosteroiduseinpatientswithsle
AT danieleek p133anifrolumabtreatmentimprovesqualityoflifeanddecreasescorticosteroiduseinpatientswithsle